Dual antiplatelet therapy for coronary stenting: a clear path for a research agenda
- PMID: 15753225
- DOI: 10.1161/01.CIR.0000158691.22229.75
Dual antiplatelet therapy for coronary stenting: a clear path for a research agenda
Comment on
-
Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study.Circulation. 2005 Mar 8;111(9):1153-9. doi: 10.1161/01.CIR.0000157138.02645.11. Epub 2005 Feb 28. Circulation. 2005. PMID: 15738352 Clinical Trial.
Similar articles
-
Clopidogrel with aspirin is the optimal antiplatelet regimen for intracoronary stenting.J Thromb Thrombolysis. 1999 Jun;7(3):227-31. doi: 10.1023/a:1008981408216. J Thromb Thrombolysis. 1999. PMID: 10373712 Review. No abstract available.
-
Aspirin and ticlopidine after routine coronary stenting: the gold standard as of 1999.J Thromb Thrombolysis. 1999 Jun;7(3):233-9. doi: 10.1023/a:1008922925054. J Thromb Thrombolysis. 1999. PMID: 10373716 Review. No abstract available.
-
Clopidogrel loading with eptifibatide to arrest the reactivity of platelets: results of the Clopidogrel Loading With Eptifibatide to Arrest the Reactivity of Platelets (CLEAR PLATELETS) study.Circulation. 2005 Mar 8;111(9):1153-9. doi: 10.1161/01.CIR.0000157138.02645.11. Epub 2005 Feb 28. Circulation. 2005. PMID: 15738352 Clinical Trial.
-
Clopidogrel as adjunctive antiplatelet therapy during coronary stenting.J Am Coll Cardiol. 1999 Dec;34(7):1884-90. doi: 10.1016/s0735-1097(99)00443-x. J Am Coll Cardiol. 1999. PMID: 10588198 Clinical Trial.
-
[The CHAMPION PHOENIX study].G Ital Cardiol (Rome). 2013 Oct;14(10):641-6. doi: 10.1714/1335.14829. G Ital Cardiol (Rome). 2013. PMID: 24121887 Italian. No abstract available.
Cited by
-
Human complement receptor type 1-directed loading of tissue plasminogen activator on circulating erythrocytes for prophylactic fibrinolysis.Blood. 2006 Sep 15;108(6):1895-902. doi: 10.1182/blood-2005-11-012336. Epub 2006 May 30. Blood. 2006. PMID: 16735601 Free PMC article.
-
Eptifibatide: a review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary intervention.Drugs. 2005;65(14):2009-35. doi: 10.2165/00003495-200565140-00007. Drugs. 2005. PMID: 16162023 Review.
-
Eptifibatide: The evidence for its role in the management of acute coronary syndromes.Core Evid. 2010 Jun 15;4:49-65. doi: 10.2147/ce.s6008. Core Evid. 2010. PMID: 20694065 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical